Bright Minds Biosciences (DRUG) Q3 2024 Earnings
DRUG·Reported December 30, 2024·Before market open
Diluted EPS came in at $-0.12, beat the $-0.44 consensus by $0.32.
Diluted EPS
$-0.12beat by $0.32
Consensus: $-0.44
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q3 2024 Earnings FAQ
Common questions about Bright Minds Biosciences's Q3 2024 earnings report.
Bright Minds Biosciences (DRUG) reported Q3 2024 earnings on December 30, 2024 before market open.
Bright Minds Biosciences reported diluted EPS of $-0.12 for Q3 2024.
EPS beat the consensus estimate of $-0.44 by $0.32.